These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10401441)

  • 1. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.
    Wahlbeck K; Cheine M; Essali A; Adams C
    Am J Psychiatry; 1999 Jul; 156(7):990-9. PubMed ID: 10401441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials.
    Tuunainen A; Wahlbeck K; Gilbody S
    Schizophr Res; 2002 Jul; 56(1-2):1-10. PubMed ID: 12084413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia.
    Avnon M; Rabinowitz J
    Br J Psychiatry; 1995 Dec; 167(6):760-4. PubMed ID: 8829743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J; Wahlbeck K; Kiviniemi V
    Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methodology on outcomes of randomised clozapine trials.
    Wahlbeck K; Tuunainen A; Gilbody S; Adams CE
    Pharmacopsychiatry; 2000 Mar; 33(2):54-9. PubMed ID: 10761820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.
    Essock SM; Frisman LK; Covell NH; Hargreaves WA
    Arch Gen Psychiatry; 2000 Oct; 57(10):987-94. PubMed ID: 11015817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on the relative efficacy of clozapine in schizophrenia.
    Jones R; MacCabe JH; Price MJ; Liu X; Upthegrove R
    Acta Psychiatr Scand; 2020 Aug; 142(2):109-120. PubMed ID: 31977065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient response and resource management: another view of clozapine treatment of schizophrenia.
    Carpenter WT; Conley RR; Buchanan RW; Breier A; Tamminga CA
    Am J Psychiatry; 1995 Jun; 152(6):827-32. PubMed ID: 7755110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination.
    Moncrieff J
    Br J Psychiatry; 2003 Aug; 183():161-6. PubMed ID: 12893670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.